Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pacira BioSciences Inc.

www.pacira.com

Latest From Pacira BioSciences Inc.

US FDA Dives Back Into Opioid Reviews Under New Division Leadership

Four new pain drug formulations are heading to advisory committees in January. The meetings will also feature new FDA leadership in the pain/addiction review division following the retirement of Sharon Hertz.

Advisory Committees Neurology

US FDA, Advisory Committees Rarely Disagree

A Milbank Quarterly study and a Pink Sheet analysis show that disagreement between the US FDA and its advisory committee meetings doesn't happen often; it is even rarer for the agency to approve a drug against the advice from a panel.

Advisory Committees Approvals

Time To Spare? US FDA “Opioid-Sparing” Guidance May Take Longer Than Expected

In August, it sounded like FDA was almost ready to issue guidance on “opioid-sparing” claims for acute pain treatments. After a November advisory committee meeting, that doesn’t seem to be the case.

Drug Approval Standards Neurology

Opioid-Sparing Claims May Be Better Suited For Phase IV Trials Instead Of Phase III

US FDA advisory committee panelists argue that prospective, randomized Phase III trials fail to reflect real-world treatment decisions.

Advisory Committees Neurology
See All

Company Information

  • Industry
  • Biotechnology
    • Liposomes
  • Medical Devices
    • Surgical Equipment & Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Neurology, Nervous System
  • Alias(es)
  • DepoTech Corp.
  • SkyePharma Inc.
  • Pacira Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pacira BioSciences Inc.
  • Senior Management
  • David M Stack, Pres. & CEO
    Charles A Reinhard, III, CFO
    Charles Laranjeira, CTO
    Richard B Scranton, MD, CMO
    Dennis McLoughlin, Chief Commercial Officer
  • Contact Info
  • Pacira BioSciences Inc.
    Phone: (973) 254-3560
    5 Sylvan Way
    Ste. 300
    Parsippany, NJ 07054
    USA
UsernamePublicRestriction

Register